The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
September 17th 2025
Net health care costs would also increase by billions of dollars should pre-exposure prophylaxis become less accessible.
September 16th 2025
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Dr Stella Safo Outlines Challenges Associated With Aging HIV Populations
May 24th 2019From the health system perspective, there needs to be improvement in treating HIV as a comprehensive disease that now goes into aging, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Watch
Reactions Are Mixed as Gilead Announces PrEP Donations, Early Launch of Generic
May 11th 2019HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic version of the pill will come to market a year early. However, some activists are skeptic.
Read More
Survey Finds Pharmacy Students Have High Awareness of PrEP but Gaps Remain
May 8th 2019Researchers from the University of Buffalo surveyed pharmacist students, finding high awareness of pre-exposure prophylaxis (PrEP) and generally positive attitudes towards it. However, the survey also revelaed gaps in knowledge, highlighting the need for more education.
Read More
Dr Stella Safo on How Changing Financial Models Might Create Management Challenges for HIV
May 1st 2019As we move away from a system of external development grants that help us maintain our HIV models to a system where our returns on investment support the work that we do, there’s a concern that there will be some slimming down of services that get patients in to our practice, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Watch
The World Health Organization recommends little to no screen time for children under age 5; senators urge HHS to ensure that government patents on the HIV prevention drug Truvada are properly licensed; New York City health officials have confirmed 31 new cases of measles in less than a week.
Read More
Antibody May Suppress HIV for Up to 4 Months in Patients Halting ART Regimens
April 22nd 2019In a study of 29 virally suppressed patients who discontinued antiretroviral therapy (ART), every patient was able to maintain viral suppression from infusions of an antibody that blocks the HIV-binding site on CD4+ T cells.
Read More
Dozens of doctors and other medical professionals have been charged with exchanging opioids and other drugs for sex and cash; the first 2 patients in the United States have been treated with CRISPR; doctors have cured infants of immunodeficiency syndrome using gene therapy made from HIV.
Read More
What We're Reading: New Medicare for All Bill; Medicaid Work Requirement Appeal; PrEP Royalties
April 11th 2019Senator Bernie Sanders, I-Vermont, has reintroduced a Medicare for All bill while other Democrats eye an alternative; the Trump administration is appealing a federal judge's decision to toss out Medicaid work requirements in Kentucky and Arkansas; AIDS activists are pushing CDC to force Gilead to give the agency royalties for Truvada.
Read More
Dr Ian Frank on the Convenience, Benefits of Single-Tablet Regimens for HIV
March 30th 2019People living with HIV who are taking single-tablet regimens have better medication adherence and lower hospitalizations than those taking multi-tablet regimens, explained Ian Frank, MD, professor of medicine, Perelman School of Medicine, University of Pennsylvania,
Watch
5 Findings From the AMCP Managed Care & Specialty Pharmacy Annual Meeting
March 29th 2019During the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmcy Annual Meeting, held March 25-28, in San Diego, California, managed care professionals from across the globe gathered to discuss opportunities and challenges facing stakeholders in pharmaceutical management, ranging from drug pricing reform to strategies to address the opioid epidemic.
Read More
What We're Reading: New Healthcare Giant; Monsanto Lawsuit; Organ Transplants From Donor with HIV
March 28th 2019Insurer Centene strikes a deal to acquire WellCare, creating a new giant in the healthcare market; a federal jury orders Monsanto to pay over $80 million to a plaintiff whose cancer was found to be caused by a common weed killer; surgeons perform a transplant using a kidney from a living donor with HIV.
Read More
Can Staggered Care Save Money While Achieving Viral Suppression in Youth With HIV?
March 27th 2019In an ongoing study, researchers seek to determine whether a staggered, "step up" intervention model could be more successful and cost-effective than standard care for achieving viral suppression in youths living with HIV.
Read More
This Week in Managed Care: March 22, 2019
March 22nd 2019This week, the top managed care news included new primary prevention guidelines that could increase the use of some diabetes drugs; the FDA expanded criteria for which patients can take part in clinical trials; a summit on value-based insurance design showed the need for tough conversations with stakeholders.
Watch
CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection
March 20th 2019The majority of new HIV infections have been found to be transmitted by individuals who are unaware that they have HIV or by those who know they have HIV but are not receiving treatment to suppress their infection.
Read More
Participation in Community Groups Found to Increase Awareness of PrEP
March 16th 2019Gay or bisexual men who participated in community groups were found have a higher awareness of pre-exposure prophylaxis (PrEP) than those who did not. PrEP has proven to be a successful preventive measure to decrease the spread of HIV.
Read More
Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding
March 12th 2019The president has released his budget for fiscal year (FY) 2020, which calls for converting Medicaid to a system of block grants and requiring all able-bodied Medicaid recipients to hold a job or perform community service. The $87.1 billion allocated to HHS, a 12% cut, would include increases to federal HIV funding, but drops in global funding, as well as cuts to the National Institutes of Health (NIH).
Read More
Dr Paul Sax Outlines Effective Treatments for Multidrug-Resistant HIV
March 9th 2019Most patients with multidrug-resistant HIV can still be treated with existing therapies, explained Paul Sax, MD, clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital and professor of medicine at Harvard University.
Watch